Chordate Medical Holding AB (FRA:K1Z) YoY EBITDA Growth : 50.92% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chordate Medical Holding AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 50.92%.

Chordate Medical Holding AB's EBITDA per Share for the three months ended in Dec. 2024 was €-0.64.

Chordate Medical Holding AB YoY EBITDA Growth Historical Data

The historical data trend for Chordate Medical Holding AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB YoY EBITDA Growth Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

61.62

99.86

-44,975.00

31.32

42.85

Chordate Medical Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															9.62	21.82	49.78	43.35	50.92

Chordate Medical Holding AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chordate Medical Holding AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-2.123	-	-3.715)	/	\| -3.715 \|
=	42.85 %

Chordate Medical Holding AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.641	-	-1.306)	/	\| -1.306 \|
=	50.92 %

Chordate Medical Holding AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CMH:Sweden

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines